Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
VRTXVertex Pharmaceuticals	$117.50bn	29.54	n/a
REGNRegeneron Pharmaceuticals	$108.00bn	27.95	n/a
MRNAModerna	$54.63bn	n/a	n/a
SGENSeagen	$43.15bn	n/a	n/a
IQVIqvia Holdings	$39.92bn	28.45	n/a
ICLRIcon	$26.86bn	35.92	n/a
BNTXBioNTech SE	$23.92bn	184.85	n/a
ALNYAlnylam Pharmaceuticals	$18.78bn	n/a	n/a
NBIXNeurocrine Biosciences	$13.63bn	36.83	n/a
KRTXKaruna Therapeutics	$12.58bn	n/a	n/a
SRPTSarepta Therapeutics	$12.27bn	n/a	n/a
UTHRUnited Therapeutics	$12.20bn	12.99	n/a
TECHBIO-TECHNE	$12.16bn	57.47	0.41%
MEDPMedpace Holdings	$11.97bn	39.37	n/a
CRLCharles River Laboratories International	$10.74bn	22.32	n/a
QGENQiagen NV	$9.60bn	25.97	n/a
RXDXPrometheus Biosciences	$9.56bn	n/a	n/a
INSMInsmed	$8.98bn	n/a	n/a
IMGNImmunoGen	$8.72bn	n/a	n/a
EXASExact Sciences	$8.39bn	n/a	n/a